Saturday 17 October 2026
Export BNR’s income statement to Excel — free account
Burning Rock Biotech Limited Sponsored ADR
BNR Healthcare Diagnostics & Research
Burning Rock Biotech Limited Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $77.2 million, up 9.18% from fiscal 2024. In the quarter to June 2026, revenue fell 4.22%, EPS fell 98.4%, free cash flow grew 46.0% and total debt fell 5.02%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years; insiders bought in the last twelve months.
12.69
2.91
−18.65%
Follow BNR
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
5 | 5 | 6 | 4 | — | — | — | — | — |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
(2.95) | (5.70) | (4.58) | (1.61) | 7.23 | 25.58 | — | — | — |
P/S ratio |
2.78 | 0.98 | 1.31 | 2.75 | 12.46 | 381.27 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
(11.46) | (12.40) | (9.52) | (4.39) | 3.10 | 13.35 | — | (11.27) | — |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Beneish M-Score |
(2.47) | (2.87) | (4.34) | (4.17) | (1.54) | — | — | — | — |
P/Operating CF |
67.70 | 21.56 | (31.36) | (19.46) | (54.37) | (1,830.84) | 0.00 | 0.00 | 0.00 |
P/B ratio |
2.80 | 0.87 | 0.92 | 1.34 | 3.43 | 64.79 | 0.00 | 0.00 | 0.00 |
Price to Tangible BV |
2.80 | 0.87 | 0.92 | 1.34 | 3.44 | 64.89 | 0.00 | 0.00 | 0.00 |
EV/Sales |
1.89 | 0.01 | 0.20 | 1.20 | 9.60 | 375.83 | 0.00 | 0.00 | 0.00 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(35.81) | (0.04) | (0.42) | (1.47) | (10.21) | (8,207.08) | 0.00 | 0.00 | 0.00 |
EV/FCF |
(8.83) | (0.02) | (0.17) | (1.47) | (10.21) | (8,207.08) | 0.00 | 0.00 | 0.00 |
Quick Ratio |
2.63 | 2.53 | 2.82 | 2.52 | 4.29 | 9.83 | 3.78 | 0.75 | — |
Current Ratio |
2.99 | 2.92 | 3.36 | 3.06 | 4.89 | 10.45 | 4.24 | 1.03 | — |
Net Debt/EBITDA |
14.48 | 1.71 | 1.15 | 1.02 | 1.94 | 5.92 | 2.48 | (0.99) | 0.00 |
Debt/Assets |
0.23% | 0.00% | 0.00% | 3.17% | 2.27% | 1.58% | 0.00% | 73.06% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.04 | 0.03 | 0.02 | 0.11 | (37.07) | — |
Asset Turnover |
0.65 | 0.53 | 0.40 | 0.28 | 0.21 | 0.29 | 2.04 | 1.16 | 0.00 |
Operating CF/Net income |
0.51 | 0.27 | 0.39 | 0.47 | 0.60 | 0.16 | 0.68 | 0.64 | 0.72 |
Capex/Depreciation |
(0.20) | (0.08) | (0.07) | (0.55) | (4.46) | (2.37) | 0.00 | 0.00 | 0.00 |
Interest Coverage |
(1,961.00) | — | — | 9,476.33 | (519.00) | (619.66) | (155.72) | (19.43) | (24.51) |
| (10.14%) | (50.57%) | (66.68%) | (61.56%) | (37.85%) | (59.51%) | 44.80% | 32.53% | 0.00% | |
| (6.64%) | (35.47%) | (48.89%) | (47.92%) | (32.66%) | (31.28%) | (178.19%) | (129.38%) | 0.00% | |
ROIC |
(61.14%) | (380.90%) | (273.06%) | (216.16%) | (126.40%) | (146.67%) | 0.00% | 0.00% | — |
Return on Tangible Assets |
(10.59%) | (62.18%) | (86.85%) | (88.36%) | (44.91%) | (19.72%) | (54.16%) | (309.58%) | 0.00% |
Average Days of Receivables |
114.74 | 107.57 | 86.16 | 71.26 | 66.26 | 74.90 | 197.84 | 138.87 | 0.00 |
Research and Development Expense of Revenue |
30.86% | 45.03% | 64.57% | 74.90% | 72.43% | 61.40% | 41.12% | 50.41% | 44.10% |
Selling, General and Administrative Expense of Revenue |
53.98% | 87.73% | 127.56% | 166.64% | 156.22% | 107.56% | 74.80% | 91.52% | 129.12% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
2.57% | 30.17% | 48.51% | 58.02% | 55.61% | 40.29% | 0.00% | 0.00% | 0.00% |
Graham Net Nets |
0.30 | 0.93 | 0.87 | 0.54 | 0.22 | 0.01 | 0.00 | 0.00 | 0.00 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(2.48%) | (21.18%) | (91.85%) | (63.89%) | (12.38%) | (1.99%) | (1.18%) | (1.18%) | (1.18%) |
Free Cash Flow Yield |
(7.71%) | (44.36%) | (87.69%) | (29.51%) | (7.55%) | (0.01%) | 0.00% | 0.00% | 0.00% |
Revenue per Share |
7.26 | 6.87 | 7.39 | 7.86 | 7.65 | 9.60 | 0.53 | 0.30 | 0.16 |
Operating CF per Share |
(0.38) | (1.23) | (3.52) | (6.37) | (7.20) | (1.64) | (0.32) | (0.22) | (0.19) |
Capex per Share |
(0.06) | (0.06) | (0.13) | (0.95) | (3.21) | (1.76) | 0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
(0.44) | (1.29) | (3.65) | (7.32) | (10.40) | (3.40) | (0.32) | (0.22) | (0.19) |
Cash per Share |
6.47 | 6.95 | 8.46 | 12.91 | 22.63 | 51.07 | 0.57 | 0.19 | 0.00 |
Shareholders Equity per Share |
7.20 | 7.73 | 10.57 | 16.16 | 27.79 | 54.06 | 0.88 | (0.01) | 0.00 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
7.20 | 7.73 | 10.57 | 16.16 | 27.79 | 54.06 | 0.88 | (0.01) | 0.00 |
Free Cash Flow |
(4.70) | (13.24) | (37.33) | (76.10) | (108.40) | (23.36) | (33.00) | (22.48) | (19.78) |
Working Capital |
70.30 | 69.91 | 87.43 | 122.85 | 227.34 | 349.75 | 76.47 | 1.21 | — |
Capital Expenditures |
(0.63) | (0.60) | (1.31) | (9.87) | (33.40) | (12.09) | (6.62) | (3.74) | (3.41) |
Net Current Asset Value |
64.85 | 64.68 | 86.27 | 120.29 | 217.76 | 349.68 | 69.78 | (12.39) | — |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.01 | 0.01 | 0.02 | 0.12 | 0.42 | 0.18 | 0.00 | 0.00 | 0.00 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | |||||||||
Depreciation/Fixed assets |
0.70 | 1.11 | 1.01 | 0.49 | 0.15 | 0.30 | 0.35 | 0.37 | 0.00 |
Cash ROIC |
(3.23%) | (8.76%) | (19.16%) | (24.60%) | (20.32%) | (3.21%) | (20.61%) | (38.88%) | 0.00% |
Accounts Receivable Turnover |
3.42 | 3.65 | 4.48 | 5.37 | 5.69 | 3.03 | 2.63 | 1.50 | 0.00 |
Accounts Payable Turnover |
3.74 | 5.87 | 4.94 | 3.07 | 2.94 | 4.93 | 7.57 | 5.25 | 2.75 |
Inventory Turnover |
2.52 | 2.30 | 1.71 | 1.39 | 1.52 | 1.89 | 2.02 | 3.15 | 1.65 |
Average Days of Payables |
108.82 | 80.28 | 37.84 | 101.51 | 160.21 | 111.67 | 41.27 | 77.53 | 117.46 |
Days of Inventory on Hand |
129.74 | 148.99 | 144.60 | 259.65 | 312.92 | 214.07 | 194.22 | 233.80 | (4.52) |
Average Receivables |
22.54 | 19.35 | 16.91 | 15.21 | 13.99 | 21.73 | 20.97 | 20.97 | — |
Average Payables |
5.22 | 3.58 | 4.97 | 8.64 | 7.67 | 3.61 | 2.07 | 2.12 | 2.12 |
Average Inventory |
7.76 | 9.15 | 14.31 | 19.12 | 14.88 | 9.38 | 7.74 | 3.54 | 3.54 |
Average Assets |
119.30 | 133.89 | 188.32 | 293.86 | 382.85 | 231.20 | 27.14 | 27.14 | — |
Average Common Equity |
78.06 | 93.90 | 138.09 | 228.76 | 330.30 | 121.53 | (107.94) | (107.94) | — |
Columns are period end dates